Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Dexpramipexole versus placebo for patients with amyotroph... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
0
Authors
Merit Cudkowicz
13 more
Merit Cudkowicz
•
Leonard Berg
11 more
•
Douglas Kerr
Published
September 23, 2013
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Neurology
Topics
Medicine
Pathology
Internal Medicine
Neurology
Genetics
Show all topics
DOI
10.1016/s1474-4422(13)70221-7